RxDoctor Payments Data

Heaven Robbins

Family · New Albany, MSNPI 1689185464

Payments from drug & device makers

$9,263in general payments, 2019–2025

Across 695 payments — averaging $13.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • GSK$1K
  • AstraZeneca$761
  • Pfizer$664
  • Lilly USA, LLC$527
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$438
  • plus $4K from 39 others

What the payments were for

  • Food & beverage$9,263100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,263 in reported general payments places this provider in the 95th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$43,465
Medicare patients
240
Services billed
2,508

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol65$48,746
OzempicSemaglutide48$46,409
JardianceEmpagliflozin31$23,041
LinzessLinaclotide18$16,675
EliquisApixaban23$14,220
GlyxambiEmpagliflozin/Linagliptin15$12,790
RybelsusSemaglutide11$10,745
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$9,503
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,670
JanuviaSitagliptin Phosphate13$7,301
Incruse ElliptaUmeclidinium Bromide16$5,409
Bevespi AerosphereGlycopyrrolate/Formoterol Fum12$5,202
Dexlansoprazole DrDexlansoprazole13$3,071
Gabapentin189$1,938
Albuterol Sulfate HfaAlbuterol Sulfate61$1,539

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Bevespi Aerosphere$761$63,45192 claims
Novo NordiskOzempic, Rybelsus$412$57,15559 claims
Boehringer IngelheimJardiance, Glyxambi$331$35,83146 claims
AbbVieLinzess$1,522$16,67518 claims
PfizerEliquis$664$14,22023 claims
GSKTrelegy Ellipta, Incruse Ellipta$1,032$13,07928 claims
MerckJanuvia$72$7,30113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,007 family providers in Mississippi.

Other family in New Albany

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →